Summary
UnitedHealth Group Inc. (UNH) filed its Form 10-Q for the quarterly period ended September 30, 2006, on March 6, 2007. This report is notable for its extensive "Explanatory Note" and "Restatement of Unaudited Condensed Consolidated Financial Statements" sections, detailing a significant accounting restatement due to historical stock option practices. The company identified a material weakness in internal controls related to stock option plan administration, accounting, and disclosure. Despite these issues, the company reported substantial revenue growth, driven by acquisitions (notably PacifiCare) and the launch of the Medicare Part D program. Financially, the period showed strong revenue increases, with consolidated revenues reaching $18.0 billion for the quarter, a 55% increase year-over-year, largely due to acquisitions and Medicare Part D. Diluted earnings per share were $0.80, up 31% from the prior year. The company also managed its cash flow effectively, generating significant operating cash flow. However, investors should be aware of the ongoing regulatory inquiries, litigation, and the potential for additional charges related to the stock option practices. The company has taken steps to remediate internal control weaknesses and improve its governance processes.
Key Highlights
- 1Consolidated revenues increased by 55% to $18.0 billion for the three months ended September 30, 2006, driven by acquisitions and Medicare Part D.
- 2Diluted earnings per share grew by 31% to $0.80 compared to the same period in the prior year.
- 3The company is undergoing a significant restatement of prior financial statements due to historical stock option practices, which led to the identification of a material weakness in internal controls.
- 4The company adopted FAS 123R (Share-Based Payment) effective January 1, 2006, requiring restatement of prior periods to reflect fair-value-based accounting for share-based compensation.
- 5Significant acquisitions, including PacifiCare Health Systems, Inc., and the launch of Medicare Part D significantly impacted the financial results and comparability.
- 6Operating cash flow remained strong, with $4.9 billion generated in the nine months ended September 30, 2006.
- 7The company has been subject to various regulatory inquiries and litigation concerning its stock option practices.